The world blood glucose device market will reach $17.32bn in 2016 predicts new visiongain report

04 September 2016
Pharma

A new report by visiongain predicts that the world infusion pumps market will reach $17.32bn in 2016. This forecast and others appears in Blood Glucose Monitoring Devices World Market Outlook 2016-2026: Glucose Test Strips, Self-Monitoring Blood Glucose Device, Non-Invasive Blood Glucose Meter, Continuous Blood Glucose Monitor published in August 2016. Visiongain is a business information provider based in London, UK.

Medical devices are playing an increasingly important role in diabetes. Products such as blood glucose monitors and insulin pumps have now become the cornerstone for the management of blood glucose levels. At the moment, more invasive devices are being increasingly used in diabetes, such as those used in bariatric surgery. While such products continue to dominate the diabetes care devices market, there is a growing interest in innovative new technologies, such as non-invasive blood glucose monitoring and continuous glucose monitoring; which can offer regular blood glucose measurements (typically every few minutes). This is particularly useful as it provides greater insight into glucose levels throughout the day.

With technology continuing to advance and the prevalence of diabetes on the rise, the blood glucose monitoring market is set for major expansion in the next decade.

“In the past decade the medical device industry has boomed. Through a merger of biology and technology, medical devices can now be used to treat some of the world’s most debilitating conditions. Changes in diet, lifestyle and demographics over the last century have led to diabetes emerging as one of the priority non-communicable disease (NCDs) targeted for action by leader through the WHO; providing visibility and funding. This push to help an estimated 422 million adults with diabetes has attracted the attention of the world’s top technology and pharmaceutical companies alike, as researchers around the world seek a method to better manage the chronic disease.“

- Arvind Deol , Pharmaceutical and Medical Device Analyst
For the purpose of this report, the focus is self-monitoring blood glucose (SMBG) devices. The market size and forecast presented in the report are for SMBG devices. This report provides an overview of the SMBG devices market with a discussion of its segments, especially those that contribute to the development of the industry.

The report focuses on the four main segments of the market:
• Glucose Test Strips
• Glucose Meters
• Continuous Glucose Monitoring
• Accessories

This report discusses the four major leading companies that dominated the self-monitoring blood glucose market. The reported dramatic increase in the diabetes population in recent years has lead medical device companies to take aim at the opportunities offered by the vast (and growing) patient pool. In the absence of a cure and with the escalating levels of diabetes worldwide, more pressure has been placed on the importance of frequent blood glucose testing, and as a result, this demand is being relayed to medical device companies to accelerate product development.

National markets are also discussed in this report, with forecasts to 2026 provided for the US, EU5 (Germany, UK, France, Italy and Spain), Japan, China, India, Brazil, Russia and Rest of the World

This report by visiongain provides SWOT analysis, identifying the strengths and weaknesses of the diabetes monitoring devices market. It also describes the opportunities and threats that will be present in the market during the forecast period. This report also provides two exclusive interviews with experts in this industry.

This independent, 165-page report guarantees you will remain better informed than your competition. With 114 tables and figures examining the blood glucose monitor market space, the report gives you a visual, one-stop breakdown of your market.

Recent News

“Generic Drugs market set to grow to $424bn by 2024” says new Visiongain report

Visiongain believes the market will see more traditional pharma companies beginning to embrace the generic business in order to take advantage of higher growth rates in this area.

14 June 2019

Read

“Global Precision Cancer Diagnostic Tests market set to grow to $21.3bn by 2024” says new Visiongain report

The market players are increasingly focusing on precision therapies where drug and precision tests are developed simultaneously.

06 June 2019

Read

“Global Antifungal Drugs market set to grow to $17bn by 2024” says new Visiongain report

Market penetration and adoption of new technologies entering the market for antifungal drugs will be crucial for market growth.

04 June 2019

Read

“Global Ophthalmic Equipment market set to grow to $75bn by 2024” says new Visiongain report

here is a growing demand for ophthalmic equipment such as vision care products and ophthalmology surgical devices, mainly due to the increasing incidence of myopia across the world.

03 June 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever